Effect of insulin glargine and nph insulin on quality of life in patients with type 2 diabetes mellitus

被引：0
作者：
Gupta, K. S. [1 ]
Gupta, U. [1 ]
机构：
[1] Maulana Azad Med Coll, New Delhi, India
来源：
VALUE IN HEALTH | 2007年 / 10卷 / 03期
关键词：
D O I：
10.1016/S1098-3015(10)68751-7
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
引用
收藏
页码：A70 / A70
页数：1
相关论文
共 50 条
[41]   Less symptomatic hypoglycemia with bedtime insulin glargine (Lantus®) compared to bedtime NPH insulin in patients with type 2 diabetes [J].
Fonseca, V ;
Bell, D ;
Mecca, T .
DIABETES, 2001, 50 :A112-A112
[42]   Nocturnal glucose metabolism after a single bedtime injection of insulin glargine or NPH insulin in patients with type 2 diabetes [J].
Fischer, Britta ;
Soydan, Nedim ;
Eckhard, Michael ;
Ehl, Julia ;
Kunz, Clemenis ;
Bretzel, Reinhard G. ;
Linn, Thomas .
DIABETES, 2006, 55 :A111-A111
[43]   Less symptomatic hypoglycemia with insulin glargine compared to NPH in patients with type 2 diabetes. [J].
Fonseca, V ;
Bell, D ;
Mecca, T .
DIABETOLOGIA, 2001, 44 :A207-A207
[44]   Insulin glargine or NPH combined with metformin in type 2 diabetes: the LANMET study [J].
H. Yki-Järvinen ;
R. Kauppinen-Mäkelin ;
M. Tiikkainen ;
M. Vähätalo ;
H. Virtamo ;
K. Nikkilä ;
T. Tulokas ;
S. Hulme ;
K. Hardy ;
S. McNulty ;
J. Hänninen ;
H. Levänen ;
S. Lahdenperä ;
R. Lehtonen ;
L. Ryysy .
Diabetologia, 2006, 49 :442-451
[45]   Insulin glargine or NPH combined with metformin in type 2 diabetes:: the LANMET study [J].
Yki-Järvinen, H ;
Kauppinen-Mäkelin, R ;
Tiikkainen, M ;
Vähätalo, M ;
Virtamo, H ;
Nikkilä, K ;
Tulokas, T ;
Hulme, S ;
Hardy, K ;
McNulty, S ;
Hänninen, J ;
Levänen, H ;
Lahdenperä, S ;
Lehtonen, R ;
Ryysy, L .
DIABETOLOGIA, 2006, 49 (03) :442-451
[46]   A meta-analysis of clinical therapeutic effect of insulin glargine and insulin detemir for patients with type 2 diabetes mellitus [J].
Zhuang, Y. G. ;
Peng, H. ;
Huang, F. .
EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES, 2013, 17 (19) :2566-2570
[47]   Insulin therapy in type 2 diabetes: A prospective 18 month comparison of insulin glargine and NPH insulin in patients with a multiple injection regimen [J].
Siegmund, T ;
Born, T ;
Weber, S ;
Usadel, KH ;
Schumm-Draeger, PM .
DIABETES, 2003, 52 :A456-A456
[48]   A Randomized Clinical Trial of Insulin Glargine and Aspart, Compared to NPH and Regular Insulin in Children with Type 1 Diabetes Mellitus [J].
Rostami, Parastoo ;
Setoodeh, Aria ;
Rabbani, Ali ;
Nakhaei-Moghadam, Maryam ;
Najmi-Varzaneh, Farnaz ;
Rezaei, Nima .
IRANIAN JOURNAL OF PEDIATRICS, 2014, 24 (02) :173-178
[49]   COMPARISON OF COSTS OF THE INSULIN TREATMENT OF TYPE 2 DIABETES MELLITUS WITH INSULIN GLARGINE AND INSULIN DETEMIR [J].
Guisasola, Alvarez F. ;
Puente, Mauricio D. ;
Coscolin, Garcia T. ;
Terres, Rubio C. .
VALUE IN HEALTH, 2010, 13 (07) :A287-A287
[50]   Immunogenicity of LY2963016 insulin glargine and Lantus® insulin glargine in Chinese patients with type 1 or type 2 diabetes mellitus [J].
Wang, Weimin ;
Song, Xiang ;
Lou, Ying ;
Du, Liying ;
Zhu, Dalong ;
Zhou, Zhiguang .
DIABETES OBESITY & METABOLISM, 2022, 24 (06) :1094-1104
12345